Swedbank AB lifted its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 5.0% during the 1st quarter, Holdings Channel reports. The firm owned 730,679 shares of the company’s stock after acquiring an additional 35,038 shares during the period. Swedbank AB’s holdings in Corteva were worth $45,982,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Nuveen LLC bought a new position in Corteva during the first quarter worth about $640,333,000. JPMorgan Chase & Co. lifted its holdings in Corteva by 54.6% during the first quarter. JPMorgan Chase & Co. now owns 5,009,038 shares of the company’s stock worth $315,219,000 after acquiring an additional 1,769,355 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Corteva by 65.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,251,449 shares of the company’s stock worth $204,615,000 after acquiring an additional 1,290,009 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Corteva by 7,135.6% during the first quarter. GAMMA Investing LLC now owns 947,789 shares of the company’s stock worth $59,644,000 after acquiring an additional 934,690 shares in the last quarter. Finally, Vanguard Group Inc. lifted its holdings in Corteva by 0.8% during the first quarter. Vanguard Group Inc. now owns 79,814,646 shares of the company’s stock worth $5,022,736,000 after acquiring an additional 639,799 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Corteva news, EVP Robert D. King sold 37,280 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the transaction, the executive vice president owned 49,262 shares of the company’s stock, valued at $3,655,240.40. The trade was a 43.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.14% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Read Our Latest Research Report on CTVA
Corteva Price Performance
NYSE:CTVA opened at $75.07 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.23 and a current ratio of 1.68. The stock’s 50-day simple moving average is $73.03 and its 200 day simple moving average is $68.11. The company has a market cap of $50.98 billion, a P/E ratio of 36.62, a P/E/G ratio of 1.67 and a beta of 0.78. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.31. The firm had revenue of $6.46 billion for the quarter, compared to the consensus estimate of $6.26 billion. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The business’s revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.83 earnings per share. As a group, sell-side analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. This is a boost from Corteva’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Tuesday, September 2nd. Corteva’s dividend payout ratio (DPR) is presently 35.12%.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Stories
- Five stocks we like better than Corteva
- What is the Dow Jones Industrial Average (DJIA)?
- Tesla’s U.S. Market Is At An 8-Year Low… How Bad Could It Get?
- What is Short Interest? How to Use It
- Congress: The Biggest Trades Impacting Markets Today
- Profitably Trade Stocks at 52-Week Highs
- 3 Companies Boosting Buybacks While Others Pull Back
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.